middle.news
How Healius Turned Pathology Pressures into $7.9M EBIT and a $60M Defence Deal
8:26am on Wednesday 18th of February, 2026 AEDT
•
Healthcare
Read Story
How Healius Turned Pathology Pressures into $7.9M EBIT and a $60M Defence Deal
8:26am on Wednesday 18th of February, 2026 AEDT
Key Points
3.8% revenue growth to $688.1 million driven by Pathology and Agilex Biolabs
Underlying EBIT improved to $7.9 million from a prior loss
No interim dividend declared for the half-year
Signed a $60 million, five-year pathology services contract with the Australian Defence Force
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
HEALIUS (ASX:HLS)
OPEN ARTICLE